© 2020 – 2024 AEA3 WEB | AEAƎ United Kingdom News
AEA3 WEB | AEAƎ United Kingdom News
Image default
Business

AstraZeneca’s vaccine is suffering from a PR problem. The economic costs could be considerable

Scientists and several regulatory agencies say its safe and the data that’s caused some to raise concerns about blood clots looks shaky, but some countries have suspended the treatment. There’s a whiff of the false MMR/autism scare in the air, writes James Moore

Related posts

‘We’re being gaslighted’: Leaseholders given huge bills despite government claim their flats are safe

AEA3

Simplicity through innovation in payments technology

AEA3

Tui reports doubled bookings in April with ‘strong summer’ ahead – and higher prices

AEA3